Production of bioactive human beta-defensin 5 and 6 in Escherichia coli by soluble fusion expression

Protein Expression and Purification

Volumn 61, Issue 2, 2008, Pages 168-174

  Huang, Lei ^a   Ching, Chi Bun ^a   Jiang, Rongrong ^a   Leong, Susanna Su Jan ^a  

^a Nanyang Technological University   (Singapore)

Author keywords

Antimicrobial activity; Antimicrobial peptide; Human defensin 5; Human defensin 6; Purification; Soluble fusion expression

Indexed keywords

ANTIINFECTIVE AGENT; BETA DEFENSIN; BETA DEFENSIN 5 PROTEIN, HUMAN; BETA DEFENSIN 6 PROTEIN, HUMAN; BETA-DEFENSIN-5 PROTEIN, HUMAN; BETA-DEFENSIN-6 PROTEIN, HUMAN; HYBRID PROTEIN;

AFFINITY CHROMATOGRAPHY; ARTICLE; BIOSYNTHESIS; DOSE RESPONSE; DRUG EFFECT; ESCHERICHIA COLI; GENETICS; HUMAN; METABOLISM; MICROBIOLOGICAL EXAMINATION; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; SOLUBILITY;

ANTI-BACTERIAL AGENTS; BASE SEQUENCE; BETA-DEFENSINS; CHROMATOGRAPHY, AFFINITY; DOSE-RESPONSE RELATIONSHIP, DRUG; ESCHERICHIA COLI; HUMANS; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION; RECOMBINANT FUSION PROTEINS; SOLUBILITY;

ESCHERICHIA COLI; STAPHYLOCOCCUS AUREUS;

EID: 50049124728     PISSN: 10465928     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pep.2008.05.016     Document Type: Article

References (16)

1. Wong J.H., Xia L.X., and Ng T.B. A review of defensins of diverse origins. Current Protein and Peptide Science 8 (2007) 446-459
2. Ganz T. Immunology-defensins and host defense. Science 286 (1999) 420-421
3. Tang Y.Q., Yuan J., Osapay G., Osapay K., Tran D., Miller C.J., Ouellette A.J., and Selsted M.E. A cyclic antimicrobial peptide produced in primate leukocytes by the ligation of two truncated alpha-defensins. Science 286 (1999) 498-502
4. Lehrer R.I., and Ganz T. Antimicrobial peptides in mammalian and insect host defence. Current Opinion in Immunology 11 (1999) 23-27
5. Bensch K.W., Raida M., Magert H.J., Schulzknappe P., and Forssmann W.G. Hbd-1-a novel beta-defensin from human plasma. FEBS Letters 368 (1995) 331-335
6. Harder J., Bartels J., Christophers E., and Schroder J.M. A peptide antibiotic from human skin. Nature 387 (1997) 861
7. Harder J., Bartels J., Christophers E., and Schroder J.M. Isolation and characterization of human beta-defensin-3, a novel human inducible peptide antibiotic. Journal of Biological Chemistry 276 (2001) 5707-5713
8. Garcia J.R.C., Krause A., Schulz S., Rodriguez-Jimenez F.J., Kluver E., Adermann K., Forssmann U., Frimpong-Boateng A., Bals R., and Forssmann W.G. Human beta-defensin 4: a novel inducible peptide with a specific salt-sensitive spectrum of antimicrobial activity. FASEB Journal 15 (2001) 1819-1821
9. Jia H.P., Schutte B.C., Schudy A., Linzmeier R., Guthmiller J.M., Johnson G.K., Tack B.F., Mitros J.P., Rosenthal A., Ganz T., and McCray P.B. Discovery of new human beta-defensins using a genomics-based approach. Gene 263 (2001) 211-218
10. Schutte B.C., Mitros J.P., Bartlettt J.A., Walters J.D., Jia H.P., Welsh M.J., Casavant T.L., and McCray P.B. Discovery of five conserved beta-defensin gene clusters using a computational search strategy. Proceedings of the National Academy of Sciences of the United States of America 99 (2002) 2129-2133
11. Yamaguchi Y., Nagase T., Makita R., Fukuhara S., Tomita T., Tominaga T., Kurihara H., and Ouchi Y. Identification of multiple novel epididymis-specific beta-defensin isoforms in humans and mice. Journal of Immunology 169 (2002) 2516-2523
12. Huang L., Wang J.F., Zhong Z.X., Peng L., Chen H.Q., Xu Z.N., and Cen P.L. Production of bioactive human beta-defensin-3 in Escherichia coli by soluble fusion expression. Biotechnology Letters 28 (2006) 627-632
13. Peng L., Xu Z.N., Fang X.M., Wang F., Yang S., and Cen P.L. Preferential codons enhancing the expression level of human beta-defensin-2 in recombinant Escherichia coli. Protein and Peptide Letters 11 (2004) 339-344
14. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analytical Biochemistry 72 (1976) 248-254
15. Hannig G., and Makrides S.C. Strategies for optimizing heterologous protein expression in Escherichia coli. Trends in Biotechnology 16 (1998) 54-60
16. Johansson A.S., Bolton-Grob R., and Mannervik B. Use of silent mutations in cDNA encoding human glutathione transferase M2-2 for optimized expression in Escherichia coli. Protein Expression and Purification 17 (1999) 105-112